Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry.
about
Galectin-3 and Beclin1/Atg6 genes in human cancers: using cDNA tissue panel, qRT-PCR, and logistic regression model to identify cancer cell biomarkersCrosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasisSilencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanomaGalectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor MicroenvironmentsLeveraging fluorinated glucosamine action to boost antitumor immunityCirculating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surfaceThe impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasisProteome serological determination of tumor-associated antigens in melanoma.Detection of differentially expressed wound-healing-related glycogenes in galectin-3-deficient mice.Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasisMolecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapyExpression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progressionChanges in the gene expression profile of A375 human melanoma cells induced by overexpression of multifunctional pigment epithelium-derived factorIL2 Inducible T-cell Kinase, a Novel Therapeutic Target in MelanomaVasculogenic mimicry is a major feature and novel predictor of poor prognosis in patients with orbital rhabdomyosarcoma.Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin.HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinomaTransient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin.The good and the bad of chemokines/chemokine receptors in melanoma.Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents.The Expression and Functional Significance of Runx2 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry and Epithelial-Mesenchymal Transition.CD133-targeted niche-dependent therapy in cancer: a multipronged approach.Galectin-3 and the skinTumor evasion from T cell surveillance.The sweet and bitter sides of galectins in melanoma progression.Melanoma biomolecules: independently identified but functionally intertwined.Why is melanoma so metastatic?Angiogenesis, vasculogenic mimicry and vascular invasion in cutaneous malignant melanoma - implications for therapeutic strategies and targeted therapies.Advanced research on vasculogenic mimicry in cancerTumor cell vascular mimicry: Novel targeting opportunity in melanoma.Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin.Lycorine hydrochloride inhibits metastatic melanoma cell-dominant vasculogenic mimicry.Hypoxia-induced vasculogenic mimicry formation via VE-cadherin regulation by Bcl-2.Circulating galectin-3 in the bloodstream: An emerging promoter of cancer metastasis.Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells.Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43.Specific c-Jun target genes in malignant melanoma.Regional immunity in melanoma: immunosuppressive changes precede nodal metastasis.Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy.Galectin-3 sensitized melanoma cell lines to vemurafenib (PLX4032) induced cell death through prevention of autophagy.
P2860
Q21134996-0F82A274-155B-4D7E-ADB4-ED1F0824CCD7Q24652518-4CE6B3E4-BBFE-4302-85ED-A8CB59E41A54Q24656407-0D45F83D-FC7B-458F-8188-9A302591C779Q26744513-1A93A244-F388-4D71-A99D-B033D044B6A2Q27008230-55F2F6E9-7A21-428B-8959-4F5AE30650A3Q28255527-6F64DEE8-C7B6-40D5-BC8A-283CA4216105Q28388257-6E240AF3-F735-4773-A49C-F93A5D0CA0B1Q33432732-2C010A26-EB7E-4BC9-8F6C-67A9B9DE2C10Q33488873-FC45A95E-C776-473B-983B-5A8200B32BACQ34285076-0AA2D760-9CBA-443E-B485-D75B71B09FDAQ34391376-4C5837B9-0540-4521-93AB-B5809DE29FBDQ34987959-A00D5252-FCD9-4644-9B32-7D07CA5BB82EQ35091440-EF92A789-30F9-4579-B855-D89FB72A4FD6Q35564248-0E6C4BED-55CA-4E43-818B-595893AE7321Q35943307-F3893491-670A-4596-8078-DDD36885A414Q36405959-CB321C93-0096-4E47-B529-CC6DE3DA6ED1Q37295329-B16421CE-E4B3-4D71-8574-EC619F047BC0Q37322616-386F5DD9-0F1F-4666-9DF2-2739B1842D81Q37394981-AF5B16D1-39D7-453C-93EB-32703A28083FQ37406706-C00944EF-BE39-4052-9949-4F049D62AD53Q37729026-AFBAACA0-2498-4861-B9FE-054080417C16Q37734881-9B9357A7-8FCE-4E84-A02F-2C660A8B737EQ37926145-8945BB43-C9CD-4EF1-BE59-2986DE70FE1FQ37970674-661BADFF-7C9D-48B9-A675-D60D422151F1Q38016538-1DABF1A4-B77D-4403-8238-2C4FBBE45BADQ38143977-65103645-564C-449B-AFC3-16579FE68C57Q38150869-83A9DFED-1215-48F1-8FFA-F04812A5655AQ38186064-F6B51896-25D9-4695-9E36-42B732CC947FQ38322795-40946564-0444-4A43-B8B1-2D48DB974437Q38710798-D2598468-3C40-4B5E-8ACD-114E0D39AAEBQ39188509-199BD3C5-BDBF-4914-80EC-E833A259257AQ39317009-037CD159-68B4-4C42-A7C9-CFEA6981A4E7Q39352857-F9949A1E-F94B-4AA6-8A1D-E90F029A5D9EQ39805251-19798569-4C75-4F2F-8040-705A238BB2CCQ41858308-EAAB55AC-6D59-4721-B080-4C6A9D5B272FQ42096781-D5C163A7-5956-4716-A843-003169C0FEEBQ42688316-AABEA722-BD81-4198-9D6F-198521B041C8Q44287609-9C929DC5-0AFC-46EC-951C-51691947DBC9Q48049656-96E82702-8086-4D8E-8969-E08B1483A5CAQ51731302-8842B850-3B5A-4C7E-B7D7-C89DF232DEAF
P2860
Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Expression profiling of Galect ...... city and vasculogenic mimicry.
@en
Expression profiling of Galect ...... city and vasculogenic mimicry.
@nl
type
label
Expression profiling of Galect ...... city and vasculogenic mimicry.
@en
Expression profiling of Galect ...... city and vasculogenic mimicry.
@nl
prefLabel
Expression profiling of Galect ...... city and vasculogenic mimicry.
@en
Expression profiling of Galect ...... city and vasculogenic mimicry.
@nl
P2093
P2860
P1476
Expression profiling of Galect ...... city and vasculogenic mimicry.
@en
P2093
Alexandra A Mourad-Zeidan
Avraham Raz
Menashe Bar-Eli
Vladislava O Melnikova
P2860
P304
P356
10.2353/AJPATH.2008.080380
P407
P577
2008-11-06T00:00:00Z